C. Jurincic-Winkler

Keyhole Limpet Hemocyanin for Carcinoma in situ of the Bladder: A Long-Term Follow-Up Study

C. Jurincic-Winkler, K. Metz, J. Beuth et al. · European Urology · 2000 · 47 citations

Medicine, Oncology, Urology +12

Effect of keyhole limpet hemocyanin (KLH) and bacillus Calmette-Guérin (BCG) instillation on carcinoma in situ of the urinary bladder.

C. Jurincic-Winkler, K. Metz, J. Beuth et al. · PubMed · 1996 · 22 citations

Medicine, Oncology, Urology +6

Comparison of an LH–RH Analogue (Goeserelin Acetate, ‘Zoladex’) with Combined Androgen Blockade in Advanced Prostate Cancer: Final Survival Results of an International Multicentre Randomized–Trial

CJ Tyrrell, J. E. Altwein, F. Klippel et al. · European Urology · 2000 · 21 citations

Medicine, Oncology, Urology +17

Antibody response to keyhole limpet hemocyanin (KLH) treatment in patients with superficial bladder carcinoma.

C. Jurincic-Winkler, H. von der Kammer, J. Beuth et al. · PubMed · 1996 · 19 citations

Medicine, Oncology, Urology +13

The potential use of prostatic secretory protein of 94 amino acid residues (PSP94) as a serum marker for prostatic tumor

H. von der Kammer, C. Jurincic-Winkler, R Horlbeck et al. · Urological Research · 1993 · 15 citations

Medicine, Biochemistry, Urology +11